Two children died from acute liver failure after receiving Zolgensma, a pricey Novartis gene therapy for a rare disease.

A U.S. federal judge ruled that Walgreens helped fuel the opioid epidemic in San Francisco by shipping thousands of “suspicious orders” of prescription drugs to its pharmacies.

Endo International, facing thousands of lawsuits alleging it fueled the opioid addiction crisis, said it is likely to file for bankruptcy imminently.

Pfizer and Valneva have begun a late-stage trial of a Lyme disease vaccine as the tick-borne illness is rapidly spreading across the U.S. and Europe.

Soon, Medicare will be able to use the full brunt of its leverage to negotiate discounts from drugmakers, like the governments in many other high-income countries.

PhRMA wrote members of Congress urging them to vote against the reconciliation package and is threatening to "hold them accountable."

Amgen will acquire ChemoCentryx for $4 billion to obtain a newly approved medicine that treats patients with a serious autoimmune condition.

A U.S. appeals court panel declined to revive a lawsuit that accused AbbVie of using a so-called patent thicket to forestall competition for Humira.

West Virginia cities and counties reached a $400 million settlement with three wholesalers over allegations they fueled an opioid crisis in the state.

Amgen is in a heated fight with the U.S. Internal Revenue Service over its international tax strategy and $10.7 billion in back taxes and penalties the agency says it is…

Drugmakers are waging an intense lobbying campaign in a last-minute attempt to bring down the revived budget reconciliation bill pushed by Democrats.

Teva Pharmaceutical reached a national settlement worth up to $4.25 billion to resolve thousands of lawsuits over its alleged role in the opioid crisis.

The FDA agreed to review a Biogen treatment for a rare, genetically defined form of ALS, even though a clinical trial failed to show a definitive benefit.

The Biden administration is preparing a sweeping initiative to develop a next generation of Covid-19 immunizations that would thwart future coronavirus variants.

With just over two month to go, it appears increasingly likely that Congress is going to miss its deadlines to pass a final FDA appropriations bill and a user-fee reauthorization.

Roche chief executive Severin Schwan will step down next March and has been nominated as chair, after 15 years at the helm.

People who work at biotechs, life sciences firms, and drugmakers pull in the largest salaries of anyone in health care — usually more than $100,000 per year.

When it comes to executive compensation in the biotech and pharma sectors, it pays to be the CEO at Regeneron Pharmaceuticals.

In the coming weeks, the U.S. Supreme Court is expected to decide whether to review a debate over patents that has the pharmaceutical industry on edge.

Teva Pharmaceuticals is taking a long-running battle over generic drug labeling to the U.S. Supreme Court.

Resistance to medicines for combating superbugs has worsened during the pandemic, with deaths and infections from several pathogens increasing at least 15%.

The New York attorney general argued that Teva Pharmaceutical lied to evade accountability for helping fuel the opioid crisis.

Perrigo has applied to the FDA for approval of what would be the first daily birth control pill available over-the-counter in the U.S.

Senate Democrats are vetting a new, tweaked version of a prescription-drug pricing package as they hurtle toward a September deadline to pass major reforms.

Companies that sell sexual health products and medicines online are shifting their marketing to highlight mail-order emergency contraception.

Some big retailers are rationing over-the-counter emergency contraceptive pills as demand spikes following the U.S. Supreme Court ruling on abortion.

Abortion pills, already used in more than half of abortions in the U.S., are becoming even more sought-after in the aftermath of Roe v. Wade being overturned.

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…

CVS Caremark will return the Eliquis blood thinner to its formulary, reversing a decision that sparked protests from physicians and patients.

Enanta Pharmaceuticals filed a lawsuit alleging the Pfizer Covid-19 pill violates a patent for its own Covid drug still in development.